Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 42.92% is in line with its 5-year average of 41.55%, near the high end of its 5-year range (32.63%–45.56%).
0.22% above its 12-month average of 42.83%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 45.56%.
GROSS MARGIN
42.92%
GROSS MARGIN AVG TTM
42.83%
GROSS MARGIN AVG 3Y
42.96%
GROSS MARGIN AVG 5Y
41.55%
GROSS MARGIN AVG 10Y
43.51%
GROSS MARGIN AVG 15Y
44.68%
GROSS MARGIN AVG 20Y
45.72%
CURRENT VS TTM AVG
+0.22%
CURRENT VS 3Y AVG
-0.09%
CURRENT VS 5Y AVG
+3.31%
CURRENT VS 10Y AVG
-1.36%
CURRENT VS 15Y AVG
-3.94%
CURRENT VS 20Y AVG
-6.12%
SECTOR MEDIAN · HEALTHCARE
59.92%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-28.38%
vs the sector median at left
NeoGenomics, Inc.
Market Cap
$470.35M
Gross Margin
42.92%
TTM Avg
42.83%
3Y Avg
42.96%
5Y Avg
41.55%
Market Cap
$389.98M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
Market Cap
$41.24M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.01B
Gross Margin
73.53%
TTM Avg
70.13%
3Y Avg
70.04%
5Y Avg
68.74%
Market Cap
$1.71B
Gross Margin
76.47%
TTM Avg
79.35%
3Y Avg
79.86%
5Y Avg
39.87%
Market Cap
$1.74B
Gross Margin
49.52%
TTM Avg
50.81%
3Y Avg
52.12%
5Y Avg
52.25%
Market Cap
$2.13B
Gross Margin
-61.96%
TTM Avg
-19.42%
3Y Avg
-14.39%
5Y Avg
23.74%
Market Cap
$2.49B
Gross Margin
84.05%
TTM Avg
-197.31%
3Y Avg
-176.53%
5Y Avg
-71811.06%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $470.35M | 42.92% | 42.83% | 42.96% | 41.55% |
| NRC Health (NRC)vs › | $459.30M | 56.33% | 58.27% | 60.30% | 61.48% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | 77.34% | 76.74% | 77.57% | 77.57% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | 73.53% | 70.13% | 70.04% | 68.74% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 76.47% | 79.35% | 79.86% | 39.87% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 49.52% | 50.81% | 52.12% | 52.25% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.13B | -61.96% | -19.42% | -14.39% | 23.74% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | 84.05% | -197.31% | -176.53% | -71811.06% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 58.69% | 59.64% | 63.22% | 64.62% |
Gross Margin
42.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 45.56% |
| 2026-03-31 | 43.32% |
| 2025-12-31 | 39.81% |
| 2025-09-30 | 42.84% |
| 2025-06-30 | 42.61% |
| 2025-03-31 | 43.59% |
| 2024-12-31 | 44.92% |
| 2024-09-30 | 44.62% |
| 2024-06-30 | 44.07% |
| 2024-03-31 | 41.90% |
| 2023-12-31 | 43.45% |
| 2023-09-30 | 41.01% |
| 2023-06-30 | 40.77% |
| 2023-03-31 | 39.95% |
| 2022-12-31 | 40.97% |
| 2022-09-30 | 37.97% |
| 2022-06-30 | 35.14% |
| 2022-03-31 | 32.63% |
| 2021-12-31 | 35.99% |
| 2021-09-30 | 38.93% |
| 2021-06-30 | 43.53% |
| 2021-03-31 | 35.98% |
| 2020-12-31 | 45.60% |
| 2020-09-30 | 43.10% |
| 2020-06-30 | 32.20% |
| 2020-03-31 | 43.73% |
| 2019-12-31 | 46.71% |
| 2019-09-30 | 48.56% |
| 2019-06-30 | 48.14% |
| 2019-03-31 | 46.62% |
| 2018-12-31 | 48.53% |
| 2018-09-30 | 46.78% |
| 2018-06-30 | 45.07% |
| 2018-03-31 | 43.05% |
| 2017-12-31 | 48.87% |
| 2017-09-30 | 45.69% |
| 2017-06-30 | 50.07% |
| 2017-03-31 | 44.09% |
| 2016-12-31 | 45.06% |
| 2016-09-30 | 45.00% |
| 2016-06-30 | 45.31% |
| 2016-03-31 | 45.51% |
| 2015-12-31 | 44.83% |
| 2015-09-30 | 44.46% |
| 2015-06-30 | 44.37% |
| 2015-03-31 | 41.45% |
| 2014-12-31 | 45.89% |
| 2014-09-30 | 44.34% |
| 2014-06-30 | 49.54% |
| 2014-03-31 | 47.90% |
| 2013-12-31 | 50.01% |
| 2013-09-30 | 48.39% |
| 2013-06-30 | 45.87% |
| 2013-03-31 | 46.28% |
| 2012-12-31 | 43.20% |
| 2012-09-30 | 41.49% |
| 2012-06-30 | 47.19% |
| 2012-03-31 | 47.12% |
| 2011-12-31 | 45.24% |
| 2011-09-30 | 44.82% |
| 2011-06-30 | 44.49% |
| 2011-03-31 | 43.90% |
| 2010-12-31 | 44.59% |
| 2010-09-30 | 44.67% |
| 2010-06-30 | 46.11% |
| 2010-03-31 | 48.40% |
| 2009-12-31 | 47.34% |
| 2009-09-30 | 49.68% |
| 2009-06-30 | 54.63% |
| 2009-03-31 | 55.29% |
| 2008-12-31 | 53.11% |
| 2008-09-30 | 49.79% |
| 2008-06-30 | 55.28% |
| 2008-05-13 | 55.34% |
| 2007-12-31 | 49.96% |
| 2007-09-30 | 51.26% |
| 2007-06-30 | 50.26% |
| 2007-05-11 | 58.23% |
| 2006-12-31 | 58.25% |
| 2006-09-30 | 55.00% |
| 2006-06-30 | 58.97% |
| 2006-03-31 | 57.07% |
| 2005-12-31 | 32.79% |
| 2005-09-30 | 44.01% |
| 2005-06-30 | 47.12% |
| 2005-03-31 | 28.49% |
| 2004-12-31 | -17.61% |
| 2004-09-30 | -8.96% |
| 2004-06-30 | -13.86% |
| 2004-03-31 | 18.38% |
| 2003-12-31 | -6.89% |
| 2003-09-30 | -41.20% |
| 2003-06-30 | -52.27% |
| 2003-03-31 | -38.30% |
| 2002-12-31 | 6.90% |
| 2002-09-30 | -119.00% |
